Drugs / control pneumococcal polysaccharide vaccine
control pneumococcal polysaccharide vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06044077 | Sep 2023 → Mar 2024 overdue | pneumococcal infection | Aimei Vacin BioPharm (Zhejiang) Co., Ltd. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | control pneumococcal polysaccharide vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06044077 ↗ |
| Modality | Vaccine | “control pneumococcal polysaccharide vaccine” NCT06044077 ↗ |